Glassman Wealth Services’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-289
| Closed | -$53K | – | 1916 |
|
|
2021
Q2 | $53K | Buy |
289
+22
| +8% | +$4.04K | 0.01% | 340 |
|
|
2021
Q1 | $41K | Buy |
267
+11
| +4% | +$1.69K | 0.01% | 365 |
|
|
2020
Q4 | $40K | Buy |
256
+29
| +13% | +$4.53K | 0.01% | 374 |
|
|
2020
Q3 | $26K | Buy |
227
+98
| +76% | +$11.2K | 0.01% | 401 |
|
|
2020
Q2 | $14K | Buy |
129
+85
| +193% | +$9.23K | ﹤0.01% | 442 |
|
|
2020
Q1 | $4K | Buy |
44
+31
| +238% | +$2.82K | ﹤0.01% | 579 |
|
|
2019
Q4 | $1K | Buy |
13
+9
| +225% | +$692 | ﹤0.01% | 1117 |
|
|
2019
Q3 | $0 | Sell |
4
-5
| -56% | – | ﹤0.01% | 1504 |
|
|
2019
Q2 | $1K | Hold |
9
| – | – | ﹤0.01% | 999 |
|
|
2019
Q1 | $1K | Sell |
9
-3
| -25% | -$333 | ﹤0.01% | 966 |
|
|
2018
Q4 | $1K | Hold |
12
| – | – | ﹤0.01% | 725 |
|
|
2018
Q3 | $2K | Hold |
12
| – | – | ﹤0.01% | 630 |
|
|
2018
Q2 | $1K | Buy |
12
+8
| +200% | +$667 | ﹤0.01% | 760 |
|
|
2018
Q1 | $0 | Sell |
4
-3
| -43% | – | ﹤0.01% | 981 |
|
|
2017
Q4 | $1K | Sell |
7
-13
| -65% | -$1.86K | ﹤0.01% | 636 |
|
|
2017
Q3 | $3K | Hold |
20
| – | – | ﹤0.01% | 405 |
|
|
2017
Q2 | $2K | Sell |
20
-21
| -51% | -$2.1K | ﹤0.01% | 435 |
|
|
2017
Q1 | $5K | Buy |
41
+29
| +242% | +$3.54K | ﹤0.01% | 406 |
|
|
2016
Q4 | $1K | Buy |
12
+9
| +300% | +$750 | ﹤0.01% | 592 |
|
|
2016
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 614 |
|